Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.
RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.
Vima Therapeutics operates as a biotechnology company.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
Enlaza Therapeutics is a biotechnology research company.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
GondolaBio researches, develops and manufactures pharmaceutical products.
Halda Therapeutics is a research-stage drug discovery company.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Frazier Life Sciences has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Frazier Life Sciences's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 10 different industry categories.
Among tracked funding rounds, Immunovant received $550.0M in a Post-IPO Equity round. Frazier Life Sciences's total known invested capital is $5.7B.
Frazier Life Sciences's average investment size is $124.8M across its portfolio of 46 companies.
Recent Frazier Life Sciences portfolio additions include Crystalys Therapeutics, RQ Bio, cAMPfield Therapeutics, Trevi Therapeutics, Sidewinder Therapeutics. These companies were founded in 2020 or later.